1. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors
2. Raltegravir
3. Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection
4. aCrescenzi; Benedetta, C.; Cristina, G.; Ester, M.; Federica, O.; Paola, P.; Giovanna, P.; Alessia, P.; Marco, P.; Michael, R.; Rita, S.; Summa, V.; Emanuela, N.U. S. Patent 7,169,780. 2007.
5. bBelyk, K. M.; Morrison, H. G.; Jones, P.; Summa, V.; Cooper, V. B.; Mahajan, A. J.; Kumke, D. J.; Tung, H.; Wai, L.; Pruzinsky, V.; Pye, P.; Angelaud, R.; Mancheno, D.U. S. Patent 20060122205. 2006.